Cogent Biosciences, Inc.

COGT · Nasdaq · SIC 2834: Pharmaceutical Preparations
156
SEC Filings

Business Summary

7 Item 1A. Risk Factors 38 Item 1B. Unresolved Staff Comments 64 Item 1C. Cybersecurity 64 Item 2. Properties 65 Item 3. Legal Proceedings 65 Item 4. Mine Safety Disclosures 65 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 66 Item 6. [Reserved] 67 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 68 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 81 Item 8....

Next Earnings

Q2 FY2026 — expected 2026-09-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCOGTdiscussed_in_filing Cybersecurity
topic_mentionCOGTdiscussed_in_filing Cybersecurity
topic_mentionCOGTdiscussed_in_filing Cybersecurity
topic_mentionCOGTdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-172025-12-310001193125-26-053334EDGAR79K words
2025-02-252024-12-310000950170-25-026115EDGAR—
2024-02-262023-12-310000950170-24-019770EDGAR—
2023-03-142022-12-310000950170-23-007729EDGAR—
2022-03-152021-12-310001564590-22-010238EDGAR—
2021-03-162020-12-310001564590-21-013325EDGAR—
2020-03-262019-12-310001564590-20-013188EDGAR—
2019-03-282018-12-310001193125-19-089299EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001193125-25-272334EDGAR27K words
2025-08-052025-06-300000950170-25-102440EDGAR—
2025-05-062025-03-310000950170-25-064005EDGAR—
2024-11-122024-09-300000950170-24-124712EDGAR—
2024-08-062024-06-300000950170-24-091229EDGAR—
2024-05-072024-03-310000950170-24-053977EDGAR—
2023-11-072023-09-300000950170-23-059769EDGAR—
2023-08-082023-06-300000950170-23-039394EDGAR—
2023-05-092023-03-310000950170-23-019166EDGAR—
2022-11-142022-09-300000950170-22-024685EDGAR—
2022-08-092022-06-300000950170-22-015760EDGAR—
2022-05-102022-03-310001564590-22-019089EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-170001193125-26-053131EDGAR3K words
2025-12-080001193125-25-311217EDGAR—
2025-11-180001193125-25-286158EDGAR—
2025-11-130001193125-25-278679EDGAR—
2025-11-100001193125-25-273315EDGAR—
2025-11-030001193125-25-261797EDGAR—
2025-09-110001193125-25-201353EDGAR—
2025-08-050000950170-25-102433EDGAR—
2025-07-100001193125-25-157390EDGAR—
2025-07-070001193125-25-155811EDGAR—

156 total filings indexed. 126 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001622229
TickerCOGT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 65df162cecb46b78a8bccf9ed316c1eb7c39d672b88c64c8a7c142cce6346428
parent: d60048896de1b9e31c07611a71d9f273ccb58d037a6fa1c4518923c388da0c0a
content hash: a796a58bd5f7a1e39c92bc004f5e03791351082eae86324bc2182e4f2991a997
signed: 2026-04-13T04:44:26.005Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf